CTLA4 and neoplasm: This is substantiated by the observations that anti-PD-1 and anti-CTLA-4 monotherapy induced high variation in overall gene expression among longitudinal tumor biopsies collected from patients prior to treatment and during therapy, whereas constant patterns of IFN-γ-related gene expression were found during treatment among responders versus nonresponders [74].